Should We Consider Recombinant Human Brain Natriuretic Peptide to Prevent Postoperative Atrial Fibrillation?

J Cardiovasc Pharmacol. 2023 Jan 1;81(1):18-20. doi: 10.1097/FJC.0000000000001375.

Authors

Marco Bernardi¹, Luigi Spadafora¹, Giuseppe Biondi-Zoccai^{2

3}

Affiliations

¹ Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
² Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy; and.
³ Mediterranea Cardiocentro, Napoli, Italy.

PMID: 36214698
DOI: 10.1097/FJC.0000000000001375

No abstract available

MeSH terms

Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / prevention & control
Atrial Natriuretic Factor
Biomarkers
Humans
Natriuretic Peptide, Brain
Peptide Fragments / therapeutic use

Substances

Natriuretic Peptide, Brain
Biomarkers
Atrial Natriuretic Factor
Peptide Fragments